C.M. Bidwell & Associates »

Blueprint Medicines shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $73k 838 87.22
2024-09-30 $77k 827 92.50

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Schwab Strategic Tr sht tm us tres (SCHO)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr 0 (SCHP)
Schwab U S Broad Market ETF (SCHB)

View all positions for C.M. Bidwell & Associates

Top funds holding Blueprint Medicines

DekaBank Deutsche Girozentrale
Van Eck Associates Corp.
IFP Advisors
Advisor Group Holdings
Huntington National Bank

View all funds holding Blueprint Medicines